ABCL vs AMZN · rev $12.4M vs P/E 31, rev $716.92B
Abcellera Biologics Inc (ABCL) versus Amazon.com Inc (AMZN) — a side-by-side from cached financials, not a winner call.
Abcellera Biologics Inc (ABCL) is a biotechnology company listed on US.
Amazon.com Inc (AMZN) is a internet retail company listed on NASDAQ. It is led by Andrew R. Jassy.
Latest reported ABCL revenue for 2026-06-30 was $12.4M. Net income was -$98.6M. Revenue was up 48.7% from 2026-03-31 to 2026-06-30. ABCL currently screens at market cap $1.12B.
Latest reported AMZN revenue for 2025-12-31 was $716.92B. Net income was $77.67B. Revenue was up 12.4% from 2024-12-31 to 2025-12-31. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
ABCL currently screens at market cap $1.12B. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
Not investment advice. Open the ABCL and AMZN stock pages for the full models.
Not investment advice.